“Stem Cells,” Regeneration, and What’s Actually in the Syringe

“Stem cells” and “regenerative medicine” are two of the most powerful phrases in orthopedics. They’re also two of the most misunderstood. If someone tells you an injection can regenerate cartilage, rebuild a tendon, or deliver millions of stem cells to repair damaged tissue, it sounds pretty compelling.

And yes, I realize I just put “stem cells” in the title of this article. It got you this far, so apparently the marketing department is onto something.

But it’s not terminology I routinely use in my office, and I certainly don’t promise patients that an injection is going to “regenerate” their damaged tissue. I’d rather spend a few extra minutes explaining what we actually know about the biology, what we’re trying to accomplish, and where the science still has questions.

So, what are you actually getting?

I work extensively with orthobiologics, including platelet-rich plasma (PRP), bone marrow aspirate concentrate (BMAC), and microfragmented adipose tissue (MFAT). These treatments involve fascinating biology, but I’m careful with the words “regenerative” and especially “stem cells.” There is an important difference between influencing the biological environment around a tissue and regenerating the tissue itself. Somewhere along the way, those two ideas have become too easy to confuse.

So What Are We Actually Doing?

I prefer the term orthobiologics. Orthobiologics use biological substances, often derived from your own body, to influence the environment around injured or degenerative tissue. That sounds less exciting than “regrowing all the stuff in your knee,” but it is also more accurate.

PRP uses concentrated platelets and plasma from your blood. Platelets release growth factors and other signaling molecules that can affect inflammation, cellular communication, blood vessel formation, and tissue remodeling. Bone marrow and adipose-derived preparations are more complex, with varying combinations of cells, proteins, signaling molecules, and other biological components.

Do some of these preparations contain cells with progenitor or stem-like properties? Yes. Is that the same as saying you are receiving a syringe full of stem cells that will turn into brand-new cartilage? No.

That distinction isn’t semantics. It’s science.

If Someone Calls It a “Stem Cell Treatment,” Ask Questions

If you are being offered a “stem cell treatment,” I think it is completely reasonable to ask a simple question: What exactly are you giving me? Where did it come from? How was it processed? What cells are actually present? How many? And what evidence shows that those cells are doing what you are being told they will do?

If the entire premise of a treatment is based on a particular type of cell being in the syringe, asking whether that cell is actually there seems like a pretty good place to start. The explanation should be clear enough to withstand those questions.

This is particularly important in Florida, where patients can encounter a wide range of practitioners, clinics, treatments, and claims in this space. The ability to offer a treatment and the scientific evidence supporting what that treatment is claimed to do are not the same thing. Our regulatory environment leaves room for treatments to be marketed in ways that can sound considerably more definitive than the underlying science.

For patients, the important part is understanding what is known, what is still being studied, and what we reasonably expect a treatment to accomplish. Orthobiologics sit in an exciting and rapidly evolving area of medicine, which means our understanding continues to change. I would much rather explain that uncertainty than fill in the gaps with certainty we don’t yet have.

Biology Is More Interesting Than the Marketing

The reason I remain excited about orthobiologics isn’t because I believe we have discovered a magic injection. It’s because we are getting better at understanding the conversations happening inside injured and degenerative tissues.

Platelets release signals. Cells respond to one another. Inflammation can be useful at one point and counterproductive at another. Blood supply, the surrounding extracellular environment, and the forces placed across a tissue all influence what happens next. A tendon is not cartilage, cartilage is not bone, and none of them behave exactly like a nerve. That complexity is what makes this field interesting.

We are trying to understand which biological signals we can influence, when we should influence them, and whether doing so actually produces a meaningful result for the patient. There is still a tremendous amount we don’t know, and I don’t view that uncertainty as a weakness of the field. Pretending the uncertainty doesn’t exist would be.

Maybe We Need Better Words

“Regenerative medicine” probably isn’t going anywhere. Neither is “stem cell therapy.” They are easy to understand, sound impressive, and fit neatly into advertising. But patients deserve to know what those labels actually mean.

The future of orthobiologics won’t come from making bigger promises. It will come from better understanding what we are putting into the syringe, what happens after we put it there, and which patients actually benefit.

So if someone tells you they can regenerate your cartilage, rebuild your tendon, or give you millions of stem cells, you don’t necessarily have to walk away. But you should ask them to explain exactly how.

Science should be able to handle the follow-up question.

Your story. Your recovery. Your Eppytome.

Have questions about what's actually in a treatment being offered to you? Let's talk it through. Call (844) 407-4070 or visit the Contact page to schedule.